Booster COVID-19 vaccine vs Omicron: thrice is nice

A third dose of an mRNA COVID-19 vaccine is necessary for robust neutralizing antibody activity vs Read more

Intestinal bacteria modulate metabolism: link to obesity

Gut bacteria produce delta-velerobetaine, which suppresses the liver's capacity to oxidize fatty Read more

rhinovirus

Vaccine vs many common cold viruses achievable

Scientists are making the case that a vaccine against rhinoviruses, the predominant cause of the common cold, is achievable.

The quest for a vaccine against rhinoviruses may have seemed quixotic, because there are more than 100 varieties circulating around the world. Even so, the immune system can handle the challenge, researchers from Emory University School of Medicine and Children’s Healthcare of Atlanta say.

Martin Moore, PhD

Martin Moore, PhD

Vaccines that combine dozens of varieties of rhinovirus at once are effective in stimulating antiviral antibodies in mice and monkeys, the researchers report in Nature Communications. The paper was also posted on Biorxiv before publication.

“We think that creating a vaccine for the common cold can be reduced to technical challenges related to manufacturing,” says Martin Moore, PhD, associate professor of pediatrics at Emory University School of Medicine and Children’s Healthcare of Atlanta. Read more

Posted on by Quinn Eastman in Immunology Leave a comment